First blood test to personalize antidepressant treatment Developed by NeuroKaire, the blood-based test creates neurons from patient samples and analyzes their response to antidepressants to guide prescribing decisions.

https://www.drugdiscoverynews.com/first-blood-test-to-personalize-antidepressant-treatment-17124 For patients seeking help for depression, starting treatment often marks the beginning of a long guessing game. More than half won’t respond to the first medication they try, and many will continue switching drugs without finding meaningful relief. That prolonged uncertainty has fueled growing calls for more personalized treatment strategies — ones that can shorten the path to effective care and reduce unnecessary suffering.